Table 1

Baseline characteristics of 9234 participants from the Copenhagen City Heart Study

Leucocyte DNA methylation of cg05575921, quintiles
All1st (highest)2nd3rd4th5th (lowest)p Value*
Number923417541783181518622020
AHRR (cg05575921) methylation extent, %56 (50–63)68 (65–71)62 (60–63)56 (54–58)51 (49–53)46 (44–48)
Women, n (%)5114 (55)1196 (68)1086 (61)935 (52)909 (49)988 (49)1×10−45
Age, years60 (47–70)59 (45–71)62 (45–73)62 (49–72)60 (50–69)59 (47–67)0.0004
Education below 10 years, n (%)5141 (56)826 (47)900 (50)991 (55)1158 (62)1266 (63)3×10−30
Body mass index, kg/m225 (22–28)25 (23–28)25 (23–28)25 (23–28)25 (22–28)24 (22–27)2×10−18
Registered COPD, n (%)152 (1.7)12 (0.7)15 (0.8)30 (1.7)38 (2.0)57 (2.8)3×10−7
FEV1/FVC ratio <Lower limit of normal, n (%)1445 (16)106 (6)116 (7)261 (15)440 (24)522 (26)4×10−104
Personal history of cancer, n (%)458 (5)89 (5)97 (5)86 (5)94 (5)92 (5)0.76
Family history of lung cancer, n (%)855 (9)157 (9)139 (8)164 (9)168 (9)227 (11)0.006
Ever smokers, n (%)7120 (77)796 (45)1029 (58)1493 (82)1802 (97)2000 (99)<10−300
Alcohol, g/week60 (12–156)48 (12–108)48 (12–120)72 (12–156)72 (24–180)84 (24–192)1×10−34
Occupational exposure to dust or fumes, n (%)1713 (19)211 (12)239 (13)314 (17)438 (24)511 (25)1×10−36
Exposure to passive smoking, n (%)3321 (36)458 (26)480 (27)600 (33)809 (44)974 (48)3×10−68
Predicted 6-year lung cancer risk†, %0.69 (0.11–2.26)0.05 (9×10−4–0.42)0.16 (0.01–0.86)0.55 (0.09–2.04)1.14 (0.30–2.83)1.26 (0.36–3.09)<10−300
  • Values are median (IQR) for continuous variables and frequencies for categorical variables.

  • *p Values were calculated with Cuzick’s extension of the Wilcoxon rank-sum test (age, alcohol and predicted lung cancer risk) or Pearson's χ2-test (categorical variables).

  • †As defined in NEJM 2013;368:728–36. Smokers only.